Guildford, UK – 24th October 2018
PrimeVigilance have become WORLDWIDE NUMBER ONE in QPPV services with 25 EU QPPV assignments, as well as 25 Deputy EU QPPVs, and our local QPPV/NPRP network covering over 60 countries !
24 October 2018.
We are pleased to share the news that Dr Jan Petracek, PrimeVigilance CEO and a leading expert in Pharmacovigilance, will be lecturing at the upcoming MHRA/DIA Excellence in Pharmacovigilance: Clinical Trials and Post-Marketing course held in London on Oct 15 – 19, 2018.
14 September 2018.
PrimeVigilance has added specialist pharmacoepidemiology and risk management services, offering best in class systematic approaches to lifecycle benefit-risk management profile optimization.
22 August 2018.
PrimeVigilance is pleased to share the news that Philippe Sorel, our Associate Director of Global Medical Information, has been invited to speak twice during the DIA Global Annual Meeting taking place on June 24-28, 2018, in Boston USA.
13 June 2018.
PrimeVigilance is proud to announce and welcome Dr. Michael Forstner as Head of Pharmacoepidemiology and Risk Management. Dr Forstner is a well-known expert in pharmacovigilance and a specialist in areas of risk management, risk minimisation, and pharmacoepidemiology in particular.
6 June 2018.
PrimeVigilance is pleased to announce that Dr. Cvijeta Bielen, our Medical Director, will be running a new webinar as a follow-up to the webinar titled “EVDAS outputs are available to MAHs – what now?” This Part 2 session takes place on Thursday 14th of June 2018 starting at 3 pm GMT (UK), 4 pm CET (Europe), and 10 am EDT (US).
21 May 2018.
+44 (0)1483 307920
(+1) 781 703 5540
United Kingdom (Head Office)